| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/26/2001 | CA2388503A1 Novel bicyclic cannabinoid agonists for the cannabinoid receptor |
| 04/26/2001 | CA2388497A1 Method of producing differentiated progenitor cells by culturing morula or inner cell mass cells |
| 04/26/2001 | CA2388421A1 Human cub-domain-containing protein and gene encoding the same |
| 04/26/2001 | CA2387962A1 A dna molecule encoding a variant .alpha.2b-adrenoceptor protein, and uses thereof |
| 04/26/2001 | CA2387892A1 Pyrazole derivatives as cannabinoid receptor antagonists |
| 04/26/2001 | CA2387846A1 Retro-anandamides, high affinity and stability cannabinoid receptor ligands |
| 04/26/2001 | CA2387840A1 Tyrosine kinase inhibitors |
| 04/26/2001 | CA2387558A1 Polyanhydrides with biologically active degradation products |
| 04/26/2001 | CA2387164A1 Anti-ischemic compounds |
| 04/26/2001 | CA2387138A1 Cannabimimetic indole derivatives |
| 04/26/2001 | CA2387034A1 4,5-disubstituted-2-aminopyrimidines |
| 04/26/2001 | CA2386922A1 Novel polypeptides and polynucleotides encoding same |
| 04/26/2001 | CA2386910A1 New oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 04/26/2001 | CA2386149A1 Allosteric sites on muscarinic receptors |
| 04/26/2001 | CA2386049A1 Bicyclic and tricyclic amines as modulators of chemokine receptor activity |
| 04/26/2001 | CA2385472A1 Isoxazolecarboxamide derivatives |
| 04/26/2001 | CA2384789A1 Synthesis and methods of use of 9-substituted guanine derivatives |
| 04/26/2001 | CA2384537A1 Modulation of angiogenesis |
| 04/26/2001 | CA2384240A1 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 04/26/2001 | CA2382978A1 Powder pharmaceutical formulations |
| 04/25/2001 | EP1094109A2 Human G protein-coupled receptor, PFI-010 |
| 04/25/2001 | EP1094075A1 Human G-protein coupled receptor |
| 04/25/2001 | EP1094071A1 Novel peptide y-2 |
| 04/25/2001 | EP1094064A1 5-arylindolederivatives and their use as serotonin(5-ht1)agonists |
| 04/25/2001 | EP1094063A1 9-(Piperazinylalkyl)carbazoles as Bax-modulators |
| 04/25/2001 | EP1093814A1 Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders |
| 04/25/2001 | EP1093457A1 Cytokine receptor common gamma chain like |
| 04/25/2001 | EP1093453A1 Naaladase inhibitors useful as pharmaceutical compounds and compositions |
| 04/25/2001 | CN1292797A Cholenic acid amides and pharmaceutical compositions thereof |
| 04/25/2001 | CN1292788A Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 04/25/2001 | CN1292785A Hypolipidemic benzothiazepine compounds |
| 04/25/2001 | CN1292782A Novel unsymmetrically substituted carboxylic acid derivatives, method for producing them, and their use as mixed ETA/ETB-receptor antagonists |
| 04/25/2001 | CN1292779A Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors |
| 04/25/2001 | CN1292704A Ginkgo leaves composition and preparation method and uses |
| 04/25/2001 | CN1292693A Indole-3-propionic acids, salts and esters thereof used as medicaments |
| 04/25/2001 | CN1292692A Oral preparations containing forskolin derivatives and process for producing medicinal preparations |
| 04/25/2001 | CN1292294A Preparation of brain-tonifying blood circulation promoting extract powder and its preparation process |
| 04/25/2001 | CN1292271A Ginseng astragalus capsule for curing hemiplegia |
| 04/25/2001 | CN1292266A Application of ammonium nilrate in pharmaceutical industry, food and health-care product |
| 04/25/2001 | CN1064956C Ortho-substd. benzoyl guanidine, its preparing method, use thereof and medicine contg. same |
| 04/25/2001 | CN1064955C Fluorine-containing benzoylguanidines |
| 04/25/2001 | CN1064954C Orthosubstituted benzoylguanidine, preparation of same, pharmaceutical containing same and application of same |
| 04/25/2001 | CN1064952C New substituted 2,2-dimethyl-omega-phenoxyalkanoic acids and esters, process for their preparation and pharmaceutical compositions containing them |
| 04/25/2001 | CN1064850C Traditional Chinese medicine preparation for curing piles and its preparing method |
| 04/24/2001 | US6222036 Reacting 2-thio-4-dimethyoxymethyl-pyrimidine with acetic acid and catalytic amount of concetrated sulfuric acid to produce 2-thiopyrimidine aldehyde |
| 04/24/2001 | US6222016 Amino acid sequence of protein involved in chromosome partitioning; drug screening of bacteriostats and bactericides; antibodies |
| 04/24/2001 | US6221901 Magnesium (-)hydroxycitrate, method of preparation, applications, and compositions in particular pharmaceutical containing same |
| 04/24/2001 | US6221881 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 04/24/2001 | US6221875 Substituted 9H-pyridino [2,3-B]indole and 9H-pyrimidino [4,5-B]indole derivatives: selective neuropeptide Y receptor ligands |
| 04/24/2001 | US6221866 Indanyl-substituted benzenecarboxamides, processes for their preparation, their use as a medicament, and pharmaceutical formulations containing them |
| 04/24/2001 | US6221856 Inositol derivatives for inhibiting superoxide anion production |
| 04/24/2001 | US6221660 Amino acid sequence; recombinant production; drug screening using membrane preparations |
| 04/24/2001 | US6221628 Nucleotide sequences coding preferential polypeptide for use in diagnosis and treatment atherosclerosis, ischemia, hypertension, restenosis and arterial inflammation |
| 04/24/2001 | US6221616 Detecting modulators of receptor binding protein; incubate cells with modulators and monitoring reduction in binding activity at receptor |
| 04/24/2001 | US6221613 Utilizing competitive binding to detect preferential modulator activity on receptor binding protein; incubate cells with modulators and monitor binding, detect amplification or reduction of binding to receptors |
| 04/24/2001 | CA2078520C Trimetazidine derivatives, process for preparing same and pharmaceutical compositions containing same |
| 04/24/2001 | CA2053277C Use of lipoxin a4 and its derivatives as antagonists for slow-reacting substances of anaphylaxis |
| 04/19/2001 | WO2001027305A1 Process for producing, methods and compositions of cholesterol lowering agents from higher basidiomycetes mushrooms |
| 04/19/2001 | WO2001027290A2 Aortic carboxypeptidase-like protein and nucleic acids encoding same |
| 04/19/2001 | WO2001027268A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 04/19/2001 | WO2001027264A1 Ribozymes to growth factor originating in human platelet |
| 04/19/2001 | WO2001027136A2 Peptides which stimulate the immune response and tissue regeneration |
| 04/19/2001 | WO2001027132A1 Estradiol conjugates and uses thereof |
| 04/19/2001 | WO2001027131A1 Purine derivatives |
| 04/19/2001 | WO2001027130A1 Purine derivatives |
| 04/19/2001 | WO2001027128A1 C-aryl glucoside sglt2 inhibitors |
| 04/19/2001 | WO2001027119A2 Substance library containing bicyclic imidazo-5-yl-amines and/or bicyclic imidazo-3-yl-amines |
| 04/19/2001 | WO2001027113A2 PYRAZOLO `4,3-d! PYRIMIDINE DERIVATIVES |
| 04/19/2001 | WO2001027109A2 Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridine-3-yl)-amine derivatives |
| 04/19/2001 | WO2001027107A2 Heterocyclic sodium/proton exchange inhibitors and method |
| 04/19/2001 | WO2001027105A1 Pyrimidine-5-carboxamide compounds, process for producing the same and use thereof |
| 04/19/2001 | WO2001027102A1 Substituted diazepanes |
| 04/19/2001 | WO2001027101A2 Anhydrous salt |
| 04/19/2001 | WO2001027090A1 m-SUBSTITUTED BENZOIC ACID DERIVATIVES EXHIBITING INTEGRINαvβ3 ANTAGONISM |
| 04/19/2001 | WO2001027089A1 Pyrimidine derivatives |
| 04/19/2001 | WO2001027088A1 Lpl potentiators |
| 04/19/2001 | WO2001027085A1 Nicotinyl aspartyl ketones as inhibitors of caspase-3 |
| 04/19/2001 | WO2001027084A1 Beta disubstituted metalloprotease inhibitors |
| 04/19/2001 | WO2001027082A1 3-AMINOPIPERIDINE DERIVATIVES AS INTEGRIN αvβ3 ANTAGONISTS |
| 04/19/2001 | WO2001027081A1 6-position substituted indoline, production and use thereof as a medicament |
| 04/19/2001 | WO2001027079A2 Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease |
| 04/19/2001 | WO2001027072A1 Hydrated n-[3-[[2-(3,4-dimethoxyphenyl) ethyl] amino] propyl] -4-nitro benzamide hydrochloride and its use in pharmaceutical compositions |
| 04/19/2001 | WO2001027071A1 Polymorphic n-[3-[[2-(3,4-dimethoxyphenyl) ethyl] amino] propyl] -4-nitro benzamide hydrochloride |
| 04/19/2001 | WO2001027070A1 Use of carbonylamino derivatives against cns disorders |
| 04/19/2001 | WO2001027068A1 Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| 04/19/2001 | WO2001026694A1 Gene therapy for cardiomyopathy |
| 04/19/2001 | WO2001026682A2 Modified plant viruses and methods of use thereof |
| 04/19/2001 | WO2001026666A2 Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba |
| 04/19/2001 | WO2001026661A1 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 04/19/2001 | WO2001014557B1 Pd-1, a receptor for b7-4, and uses therefor |
| 04/19/2001 | WO2001002565A3 Secreted protein zacrp4 |
| 04/19/2001 | WO2000076309A3 Non-human transgenic animals deficient in gas6 function and their use |
| 04/19/2001 | WO2000074707A3 Use of interleukin-11 to treat hemorrhagic shock |
| 04/19/2001 | WO2000073274A3 Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors |
| 04/19/2001 | WO2000068380A3 Extracellular matrix and adhesion-associated proteins |
| 04/19/2001 | WO2000066730A3 Laminin 2 and methods for its use |
| 04/19/2001 | WO2000061568A3 1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar radicals, methods for the production thereof, medicaments containing these compounds and the use thereof |
| 04/19/2001 | WO2000046198A8 Anti-inflammatory indole derivatives |
| 04/19/2001 | WO2000026245A3 Human membrane transport proteins |
| 04/19/2001 | WO2000012720A9 Elongase genes and uses thereof |